SCHEMBL1061138

SCHEMBL1061138

O=C1NC(=S)N/C1=C/c1ccc(-c2ccccc2)s1

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRF1 P14222 19/20 0.77
▸ TOP1 P11387 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1061140 1.00 PRF1 (0.77) PRF1TOP1
SCHEMBL12634251 0.87 PRF1 (1.00) PRF1TOP1
SCHEMBL14761474 0.87 PRF1 (1.00) PRF1TOP1
SCHEMBL2022040 0.87 PRF1 (1.00) PRF1TOP1
SCHEMBL2022038 0.87 PRF1 (1.00) PRF1TOP1
SCHEMBL2022037 0.87 PRF1 (1.00) PRF1TOP1
SCHEMBL13056365 0.87 PRF1 (0.60) PRF1TOP1
SCHEMBL5142516 0.87 PRF1 (0.82) PRF1TOP1
SCHEMBL5142515 0.87 PRF1 (0.82) PRF1TOP1
SCHEMBL2038859 0.86 PRF1 (1.00) PRF1TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735445-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2014-05-27 — — US disclosed
EP-1594438-B1 Use of an inhibitor of 15-hydroxyprostaglandin dehydrogenase in order to stimulate pigmentation of the skin or hair OREAL (FR) 2013-07-17 — — EP disclosed
US-20110014250-A1 INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES L'OREAL (FR) 2011-01-20 — — US disclosed
US-7705041-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2010-04-27 — — US disclosed
US-20080076809-A1 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses SOCIETE L'OREAL S.A. (FR) 2008-03-27 — — US disclosed
US-7294641-B2 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses L'OREAL (FR) 2007-11-13 — — US disclosed
US-20060034786-A1 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2006-02-16 — — US disclosed
US-20060008436-A1 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses SOCIETE L'OREAL S.A. (FR) 2006-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076809-A1 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses KRT18, FGF1, SHH PRF1 2632/4885TOP1 879/4885
US-20060034786-A1 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages COX15, HPGD, TYR PRF1 3750/4885TOP1 2749/4885
US-20110014250-A1 INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES COX15, HPGD, TYR PRF1 3750/4885TOP1 2749/4885
US-20060008436-A1 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses KRT18, SHH, FGF1 PRF1 4111/4885TOP1 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback